Attività scientifica

Pubblicazioni scientifiche

U.O. Oncologia

  1. miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR.
    de Biase D, Visani M, Morandi L, Marucci G, Taccioli C, Cerasoli S, Baruzzi A,    Pession A; PERNO Study Group. PLoS One. 2012;7(4):e35596. Epub 2012 Apr 18
  2. Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study.
    Guarneri V, Frassoldati A, Bottini A, Cagossi K, Bisagni G, Sarti S, Ravaioli A,     Cavanna L, Giardina G, Musolino A, Untch M, Orlando L, Artioli F, Boni C, Generali DG, Serra P, Bagnalasta M, Marini L, Piacentini F, D'Amico R, Conte P.J Clin Oncol. 2012 Jun 1;30(16):1989-95. Epub 2012 Apr 9
  3. A new informed consent form model for cancer patients: preliminary results of a prospective study by the Italian Association of Medical Oncology (AIOM).
    Gori S, Greco MT, Catania C, Colombo C, Apolone G, Zagonel V; AIOM Group for the Informed Consent in Medical Oncology.  Patient Educ Couns. 2012 May;87(2):243-9. Epub 2011 Sep 16.
  4. Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw.
    Cella L, Oppici A, Arbasi M, Moretto M, Piepoli M, Vallisa D, Zangrandi A, Di Nunzio C, Cavanna L.
    Head Face Med. 2011 Aug 17;7:16.
  5. Return to work after treatment for breast cancer.
    Cavanna L, Ambroggi M, Stroppa E, Di Nunzio C, Dallanegra L, Monfredo M.
    Breast Cancer Res Treat. 2011 Jul;128(1):287-8. Epub 2011 Feb 16. No abstract available.
  6. Cerebrospinal fluid cytology diagnosis of HER2-positive leptomeningeal carcinomatosis from HER2-positive metastatic gastric cancer: case report.
    Cavanna L, Rocchi A, Gorgni S, Ambroggi M, Foroni RP, Ubbiali A, Civardi G.
    J Clin Oncol. 2011 May 1;29(13):e367-8. Epub 2011 Feb 7. No abstract available.
  7. Ultrasound-guided central venous catheterization in cancer patients improves the success rate of cannulation and reduces mechanical complications: a prospective observational study of 1,978 consecutive catheterizations.
    Cavanna L, Civardi G, Vallisa D, Di Nunzio C, Cappucciati L, Bertè R, Cordani MR, Lazzaro A, Cremona G, Biasini C, Muroni M, Mordenti P, Gorgni S, Zaffignani E, Ambroggi M, Bidin L, Palladino MA, Rodinò C, Tibaldi L.
    World J Surg Oncol. 2010 Oct 19;8:91.
  8. Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer Pain Outcome Research Study Group.
    Greco MT, Corli O, Montanari M, Deandrea S, Zagonel V, Apolone G; Writing Protocol Committee; Cancer Pain Outcome Research Study Group (CPOR SG) Investigators.
    Clin J Pain. 2011 Jan;27(1):9-18.
  9. Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.
    Celio L, Frustaci S, Denaro A, Buonadonna A, Ardizzoia A, Piazza E, Fabi A, Capobianco AM, Isa L, Cavanna L, Bertolini A, Bichisao E, Bajetta E; Italian Trials in Medical Oncology Group.
    Support Care Cancer. 2011 Aug;19(8):1217-25. Epub 2010 Jun 25.
  10. Ultrasound guidance of central venous catheterization: towards a zero risk of iatrogenic pneumothorax.
    Cavanna L, Anselmi E, Di Nunzio C.
    Thorac Cardiovasc Surg. 2010 Jun;58(4):255. Epub 2010 May 31. No abstract available.
  11. The medical oncologist's role in palliative care: AIOM's position.
    Zagonel V, Cavanna L, Cetto G, Ciaparrone M, Di Rocco C, Franciosi V, Maltoni M, Marchetti P, Martoni A, Mastromauro C, Mazzoli M, Moro C, Pinto C, Porzio G, Trentin L, Boccardo F; Task Force AIOM Palliative Care in Oncology.
    Tumori. 2009 Nov-Dec;95(6):652-4. No abstract available.
  12. Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.
    Colucci G, Labianca R, Di Costanzo F, Gebbia V, Cartenì G, Massidda B, Dapretto E, Manzione L, Piazza E, Sannicolò M, Ciaparrone M, Cavanna L, Giuliani F, Maiello E, Testa A, Pederzoli P, Falconi M, Gallo C, Di Maio M, Perrone F; Gruppo Oncologico Italia Meridionale (GOIM); Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente (GISCAD); Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC).
    J Clin Oncol. 2010 Apr 1;28(10):1645-51. Epub 2010 Mar 1.
  13. Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study).
    Piepoli MF, Vallisa D, Arbasi M, Cavanna L, Cerri L, Mori M, Passerini F, Tommasi L, Rossi A, Capucci A; Cardiac Study Group.
    Eur J Heart Fail. 2010 Feb;12(2):172-80. Epub 2009 Dec 30.
  14. Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group.
    Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT; Cancer Pain Outcome Research Study Group (CPOR SG) Investigators, Apolone G, Bertetto O, Caraceni A, Corli O, De Conno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F.
    Clin J Pain. 2009 Oct;25(8):671-82.
  15. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
    Agnelli G, Gussoni G, Bianchini C, Verso M, Mandalà M, Cavanna L, Barni S, Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V, Bonizzoni E, Tonato M; PROTECHT Investigators.
    Lancet Oncol. 2009 Oct;10(10):943-9. Epub 2009 Aug 31.
  16. Elderly cancer patients' preferences regarding the disclosure of cancer diagnosis. Experience of a single institution in Italy.
    Cavanna L, Di Nunzio C, Seghini P, Anselmi E, Biasini C, Artioli F, Mordenti P.
    Tumori. 2009 Jan-Feb;95(1):63-7.
  17. Prospective, multicenter, randomized trial of a new organizational modality for providing information and support to cancer patients.
    Passalacqua R, Caminiti C, Campione F, Diodati F, Todeschini R, Bisagni G, Labianca R, Dalla Chiesa M, Bracci R, Aragona M, Artioli F, Cavanna L, Masina A, De Falco F, Marzocchini B, Iacono C, Contu A, Di Costanzo F, Bertetto O, Annunziata MA.
    J Clin Oncol. 2009 Apr 10;27(11):1794-9. Epub 2009 Mar 9.
  18. WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Alessandrino EP, Della Porta MG, Bacigalupo A, Van Lint MT, Falda M, Onida F, Bernardi M, Iori AP, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Malcovati L, Pascutto C, Oneto R, Fanin R, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Blood. 2008 Aug 1;112(3):895-902. Epub 2008 May 22.
  19. High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature.
    Cavanna L, Pagani R, Seghini P, Zangrandi A, Paties C.
    World J Surg Oncol. 2008 Mar 19;6:35. Review.
  20. Osteonecrosis of the jaw. A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates. Report of five cases and review of the literature.
    Cavanna L, Bertè R, Arcari A, Mordenti P, Pagani R, Vallisa D.
    Eur J Intern Med. 2007 Sep;18(5):417-22. Epub 2007 Jul 13.
  21. Cancer diagnosis disclosure in a northern Italian hospital. Report on 312 consecutive cancer patients.
    Cavanna L, Anselmi E, Lazzaro A, Seghini P, Di Nunzio C, Dallanegra L, Monfredo M.
    Tumori. 2007 May-Jun;93(3):290-1.
  22. Role of image-guided fine-needle aspiration biopsy in the management of patients with splenic metastasis.
    Cavanna L, Lazzaro A, Vallisa D, Civardi G, Artioli F.
    World J Surg Oncol. 2007 Feb 2;5:13.
  23. Colon carcinoma metastasis to the thyroid gland.
    Cavanna L, Anselmi E, Palladino M, Pagani R.
    Tumori. 2006 Sep-Oct;92(5):467. No abstract available.
  24. Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.
    Scartozzi M, Falcone A, Pucci F, Braconi C, Pierantoni C, Cavanna L, Franciosi V, Berardi R, Beretta G, Masi G, Allegrini G, Zaniboni A, Labianca R, Cascinu S.
    Tumori. 2006 Sep-Oct;92(5):384-8.
  25. Jaw avascular bone necrosis associated with long-term use of bisphosphonates.
    Bertè R, Arcari A, Bernuzzi P, Anselmi E, Lazzaro A, Moroni CF, Vallisa D, Cavanna L.
    Tumori. 2006 Jul-Aug;92(4):361. No abstract available.
  26. Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC).
    Cavanna L, Artioli F, Codignola C, Lazzaro A, Rizzi A, Gamboni A, Rota L, Rodinò C, Boni F, Iop A, Zaniboni A.
    Am J Clin Oncol. 2006 Aug;29(4):371-5.
  27. Primary pancreatic lymphoma. A report of five cases.
    Arcari A, Anselmi E, Bernuzzi P, Berta R, Lazzaro A, Moroni CF, Trabacchi E, Vallisa D, Vercelli A, Cavanna L.
    Haematologica. 2005 Jan;90(1):ECR09. No abstract available.
  28. A singular case of multiple myeloma and primary biliary cirrhosis strictly associated in pathogenesis and response to alkylating therapy.
    Lazzaro A, Bernuzzi P, Arcari A, Bertè R, Moroni FC, Trabacchi E, Vallisa D, Cavanna L.
    Am J Hematol. 2006 Jul;81(7):557. No abstract available.
  29. Post-traumatic glioma: report of two cases.
    Anselmi E, Vallisa D, Bertè R, Vanzo C, Cavanna L.
    Tumori. 2006 Mar-Apr;92(2):175-7.
  30. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.
    Clin Cancer Res. 2006 Jan 15;12(2):529-35.
  31. Presentation of esophageal cancer with solitary splenic metastasis.
    Cavanna L, Lazzaro A, Trabacchi E, Anselmi E, Vallisa D, Foroni RP.
    Am J Clin Oncol. 2005 Dec;28(6):636-7. No abstract available.
  32. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M; Intergruppo Italiano Linfomi.
    J Clin Oncol. 2005 Dec 20;23(36):9198-207. Epub 2005 Sep 19.
  33. [Thrombotic thrombocytopenic purpura: report of seven cases].
    Anselmi E, Arcari A, Bernuzzi P, Civardi G, Moroni CF, Vallisa D, Bertè R, Lazzaro A, Cavanna L.
    Ann Ital Med Int. 2005 Apr-Jun;20(2):108-12. Italian.
  34. Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases.
    Cavanna L, Bertè R, Bidin L, Civardi G, Anselmi E, Lazzaro A, Moroni CF, Palladino MA, Rodinò C, Vallisa D.
    J Chemother. 2005 Jun;17(3):334-8.
  35. Primary pancreatic lymphoma. Report of five cases.
    Arcari A, Anselmi E, Bernuzzi P, Bertè R, Lazzaro A, Moroni CF, Trabacchi E, Vallisa D, Vercelli A, Cavanna L.
    Haematologica. 2005 Feb;90(2):ECR09.
  36. Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
    Luppi M, Trovato R, Barozzi P, Vallisa D, Rossi G, Re A, Ravazzini L, Potenza L, Riva G, Morselli M, Longo G, Cavanna L, Roncaglia R, Torelli G.
    Leukemia. 2005 Mar;19(3):473-6. No abstract available.
  37. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.
    Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R, Lazzaro A, Trabacchi E, Anselmi E, Arcari AL, Moroni C, Bertè R, Lazzarino M, Cavanna L.
    J Clin Oncol. 2005 Jan 20;23(3):468-73.
  38. Primary lung lymphoma.
    Vallisa D, Trabacchi E, Cavanna L.
    Curr Drug Targets Inflamm Allergy. 2004 Dec;3(4):469-71. Review.
  39. Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia.
    Imberti D, Vallisa D, Anselmi E, Moroni CF, Bertè R, Lazzaro A, Bernuzzi P, Arcari AL, Cavanna L.
    Tumori. 2004 Jul-Aug;90(4):390-3.
  40. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
    Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M.
    Leukemia. 2004 Sep;18(9):1512-7.
  41. On the need of biopsy confirmation at suspected first recurrence of cancer.
    Cavanna L, Vallisa D, Lazzaro A, Civardi G, Bertè R, Moroni CF, Bernuzzi P, Arcari A, Anselmi E.
    Am J Clin Oncol. 2004 Apr;27(2):212-3. No abstract available.
  42. The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.
    Rigacci L, Federico M, Martelli M, Zinzani PL, Cavanna L, Bellesi G, Merli F, Alterini R, Petrucci MT, Tani M, Liberati AM, Vitolo U, Pavone V, Cuneo A, Chisesib T, Brugiatelli M; Intergruppo Italiano Linfomi.
    Leuk Lymphoma. 2003 Nov;44(11):1911-7.
  43. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L, Paulli M, Boveri E, Vallisa D, Bernuzzi P, Orlandi E, Incardona P, Brusamolino E, Passamonti F, Burcheri S, Schena C, Pascutto C, Cavanna L, Magrini U, Lazzarino M.
    Cancer. 2004 Jan 1;100(1):107-15.
  44. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
    Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M; Hematology/Oncology Studies and Trials (HOST) Group, Italy.
    Semin Oncol. 2003 Apr;30(2):172-7.
  45. Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi.
    Baldini L, Brugiatelli M, Luminari S, Lombardo M, Merli F, Sacchi S, Gobbi P, Liberati M, Cavanna L, Colombi M, Stelitano C, Goldaniga M, Morabito F, Federico M, Silingardi V; Gruppo Italiano per lo Studio dei Linfomi.
    J Clin Oncol. 2003 Apr 15;21(8):1459-65.
  46. Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).
    Lombardo M, Morabito F, Merli F, Molica S, Cavanna L, Sacchi S, Broglia C, Angrilli F, Ilariucci F, Stelitano C, Luisi D, Bertè R, Luminari S, Federico M, Brugiatelli M; GISL.
    Leuk Lymphoma. 2002 Sep;43(9):1795-801.
  47. Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.
    Riccardi A, Mora O, Tinelli C, Porta C, Danova M, Brugnatelli S, Grasso D, Tolcà B, Spanedda R, De Paoli A, Barbarano L, Cavanna L, Giordano M, Delfini C, Nicoletti G, Bergonzi C, Rinaldi E, Piccinini L, Ascari E.
    Eur J Cancer. 2003 Jan;39(1):31-7.
  48. Focal liver lesions in non-Hodgkin's lymphoma: investigation of their prevalence, clinical significance and the role of Hepatitis C virus infection.
    Civardi G, Vallisa D, Bertè R, Lazzaro A, Moroni CF, Cavanna L.
    Eur J Cancer. 2002 Dec;38(18):2382-7.
  49. Advanced waldenström's macroglobulinemia: a case of possible cure after systemic chemotherapy, splenic radiation and splenectomy.
    Cavanna L, Bertè R, Lazzaro A, Vallisa D, Moroni CF, Civardi G.
    Acta Haematol. 2002;108(2):97-101. Review.
  50. Human herpesvirus 8-associated primary effusion lymphoma in HIV--patients: a clinicopidemiologic variant resembling classic Kaposi's sarcoma.
    Ascoli V, Lo Coco F, Torelli G, Vallisa D, Cavanna L, Bergonzi C, Luppi M.
    Haematologica. 2002 Apr;87(4):339-43. Review. No abstract available.
  51. We treat patients and we do not treat disease.
    Cavanna L, Bertè R, Civardi G, Vallisa D, Lazzaro A, Moroni CF.
    Hematol J. 2001;2(3):212. No abstract available.
  52. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
    Bertè R, Vallisa D, Civardi G, Moroni CF, Lazzaro A, Cavanna L.
    Acta Haematol. 2001;106(3):141-2. No abstract available.
  53. Sweet's syndrome associated with monosomy 7 myelodysplastic syndrome.
    Nifosì G, Sbolli G, Ferrari B, Berte' R, Vallisa D, Civardi G, Cavanna L.
    Eur J Intern Med. 2001 Jul;12(4):380-383.
  54. Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low risk in a multicenter Italian study.
    Civardi G, Vallisa D, Bertè R, Giorgio A, Filice C, Caremani M, Caturelli E, Pompili M, De Sio I, Buscarini E, Cavanna L.
    Am J Hematol. 2001 Jun;67(2):93-9.
  55. BCR-ABL rearrangement is not detectable in essential thrombocythemia.
    Emilia G, Marasca R, Zucchini P, Temperani P, Luppi M, Torelli G, Lanza F, De Angelis C, Gandini D, Castoldi GL, Vallisa D, Cavanna L, del Senno L.
    Blood. 2001 Apr 1;97(7):2187-9. No abstract available.
  56. ALK positive lymphohistiocytic variant of anaplastic large cell lymphoma in an adult.
    Paulli M, Vallisa D, Viglio A, Boveri E, Kindl S, Vassallo G, Magrini U, Cavanna L.
    Haematologica. 2001 Mar;86(3):260-5.
  57. Peri-lesional injections of granulocyte-macrophage colony-stimulating factor in the management of chronic leg ulcers in type II mixed cryoglobulinemia.
    Cavanna L, Bertè R, Vallisa D, Civardi G, Ferrari B, Moroni F.
    Haematologica. 2000 Sep;85(9):1007-8. No abstract available.
  58. Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
    Gobbi PG, Broglia C, Bertè R, Petrilli MP, Molica S, Angrilli F, Iannitto E, Ghirardelli ML, Di Renzo N, Cavanna L, Ascari E.
    Haematologica. 2000 Jul;85(7):722-8.
  59. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.
    Stelitano C, Baldini L, Pieresca C, Callea V, Angrilli F, Clò V, Partesotti G, Merli F, Cavanna L, Morabito F, Federico M, Brugiatelli M, Silingardi V.
    Haematologica. 2000 Feb;85(2):154-9.
  60. Primary adrenal non-Hodgkin's lymphoma associated with autoimmune hemolytic anemia: a case diagnosed by ultrasound-guided fine needle biopsy.
    Cavanna L, Civardi G, Vallisa D, Bertè R.
    Ann Ital Med Int. 1999 Oct-Dec;14(4):298-301. Review.
  61. Color-Doppler in the imaging work-up of primary hyperparathyroidism.
    Meola M, Barsotti M, Lenti C, Luperini M, Cavanna L, Barsotti G.
    J Nephrol. 1999 Jul-Aug;12(4):270-4.
  62. Clinical experiences with emergency ultrasound guided diagnostic and therapeutic procedures in a department of internal medicine.
    Civardi G, Vallisa D, Bertè R, Buscarini E, Silva M, Cavanna L.
    Ann Ital Med Int. 1999 Apr-Jun;14(2):74-8.
  63. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course.
    Vallisa D, Bertè R, Rocca A, Civardi G, Giangregorio F, Ferrari B, Sbolli G, Cavanna L.
    Am J Med. 1999 May;106(5):556-60.
  64. Ultrasound image of massive inferior vena cava thrombosis causing asymptomatic subclinical disseminated intravascular coagulation.
    Cavanna L, Civardi G, Vallisa D.
    Haematologica. 1998 Nov;83(11):1041-2. No abstract available.
  65. Parental origin of chromosomes 9 and 22 involved in the Ph chromosome translocation in chronic myelocytic leukemia.
    Maserati E, Seghezzi L, Pasquali F, Locatelli F, Viero P, Cavanna L.
    Cancer Genet Cytogenet. 1998 Dec;107(2):151-2. No abstract available.
  66. High prevalence of anti-HGV/E2 antibodies in HCV-positive patients with non Hodgkin's lymphoma.
    Civardi G, Tanzi E, Ferrari B, Vallisa D, Zanetti A, Cavanna L.
    Haematologica. 1998 Oct;83(10):957-8.
  67. Extramedullary plasmacytoma in a patient with AIDS: report of a case and review of the literature.
    Vallisa D, Pagani L, Bertè R, Civardi G, Viale P, Paties C, Cavanna L.
    Tumori. 1998 Jul-Aug;84(4):511-4. Review.
  68. Clinical efficacy of ultrasound guided percutaneous drainage of abscesses in patients with leukaemia and lymphoma.
    Civardi G, Filice C, Caremani M, Giorgio A, Vallisa D, Berté R, Cavanna L.
    Eur J Cancer. 1998 Mar;34(4):580-3.
  69. Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.
    Luppi M, Longo G, Ferrari MG, Barozzi P, Marasca R, Morselli M, Valenti C, Mascia T, Vandelli L, Vallisa D, Cavanna L, Torelli G.
    Ann Oncol. 1998 May;9(5):495-8.
  70. Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on ET.
    Sacchi S, Gugliotta L, Papineschi F, Liberati AM, Rupoli S, Delfini C, Ruggeri M, Cavanna L, Bucalossi A, Benedetti E, Ferrandina C, Vinci G, Morselli M, Torelli G.
    Leukemia. 1998 Mar;12(3):289-94.
  71. A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
    Baldini L, Guffanti A, Gobbi P, Colombi M, Federico M, Avanzini P, Cavanna L, Pieresca C, Silingardi V, Maiolo AT.
    Cancer. 1997 Mar 15;79(6):1234-40.
  72. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG, Pieresca C, Cavanna L, Corbella F, Vallisa D, Federico M, Formisano R, Carotenuto M, Merli F, Callea V, Angrilli F, Silingardi V.
    Haematologica. 1996 Nov-Dec;81(6):503-12.
  73. Oral idarubicin and prednisone for advanced, previously untreated, multiple myeloma: a pilot study. Cooperative Group of Study and Treatment of Multiple Myeloma.
    Brugnatelli S, Riccardi A, Ucci G, Petrini M, Giordano M, Barbarano L, Bergonzi C, De Paoli A, Cavanna L, Ascari E.
    Ann Oncol. 1996 Jul;7(5):537-8. No abstract available.
  74. In vivo biological response following low-dose interleukin-2 in complete remission B-cell non-Hodgkin's lymphoma patients. Italian Lymphoma Study Group (GISL).
    Vecchi A, Cavanna L, Avanzini P, Callea V, Velardi A, Albi N, Tartoni P, Bensi L, Valentini P, Longo R, Sacchi S.
    Eur J Haematol. 1996 Jul;57(1):33-7.
  75. Meningeal involvement in multiple myeloma: report of a case with cytologic and immunocytochemical diagnosis.
    Cavanna L, Invernizzi R, Berte' R, Vallisa D, Buscarini L.
    Acta Cytol. 1996 May-Jun;40(3):571-5.
  76. Diagnostic imaging of primary hepatic leiomyosarcoma: a case report.
    Civardi G, Cavanna L, Iovine E, Buscarini E, Vallisa D, Buscarini L.
    Ital J Gastroenterol. 1996 Feb-Mar;28(2):98-101. Review.
  77. Low-dose interferon alpha treatment in essential thrombocythemia.
    Berte R, Vallisa D, Ferrari B, Civardi G, Sbolli G, Cavanna L.
    Eur J Haematol. 1996 Jan-Feb;56(1-2):104-5. No abstract available.
  78. High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders.
    Cavanna L, Sbolli G, Tanzi E, Romanò L, Civardi G, Buscarini E, Vallisa D, Berté R, Rossi A.
    Haematologica. 1995 Sep-Oct;80(5):486-7. No abstract available.
  79. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma.
    Rossi S, Di Stasi M, Buscarini E, Cavanna L, Quaretti P, Squassante E, Garbagnati F, Buscarini L.
    Cancer J Sci Am. 1995 May-Jun;1(1):73-81.
  80. Primary lymphoma of the spleen. Report of a case with diagnosis by fine-needle guided biopsy.
    Cavanna L, Artioli F, Vallisa D, Di Donato C, Bertè R, Carapezzi C, Foroni R, Del Vecchio C, Lo Monaco B, Prati R.
    Haematologica. 1995 May-Jun;80(3):241-3.
  81. ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL).
    Silingardi V, Federico M, Cavanna L, Avanzini P, Gobbi PG, Lombardo M, Carotenuto M, Frassoldati A, Pieresca C, Vallisa D, et al.
    Leuk Lymphoma. 1995 Apr;17(3-4):313-20.
  82. Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. A report from the Italian Lymphoma Study Group (GISL).
    Federico M, Gobbi PG, Moretti G, Avanzini P, Di Renzo N, Cavanna L, Ascari E, Silingardi V.
    Am J Clin Oncol. 1995 Feb;18(1):8-14.
  83. Autoimmune thyroid dysfunctions in hematologic malignancies treated with alpha-interferon.
    Vallisa D, Cavanna L, Berté R, Merli F, Ghisoni F, Buscarini L.
    Acta Haematol. 1995;93(1):31-5.
  84. Hepatocellular carcinoma and B-cell tumors.
    Di Stasi M, Sbolli G, Fornari F, Cavanna L, Rossi S, Buscarini E, Civardi G, Vallisa D, Berte R, Buscarini L.
    J Hepatol. 1994 Dec;21(6):1146-7. No abstract available.
  85. Severe immune thrombocytopenic purpura relapse after alpha-interferon in chronic myeloid leukemia, successfully treated with cyclosporine.
    Cavanna L, Vallisa D, Berte R, Buscarini E, Fornari F, Di Stasi M, Civardi G, Buscarini L.
    Am J Hematol. 1994 Nov;47(3):255-6. No abstract available.
  86. Small (< or = 3 cm) hepatic lesions. Results of sonographically guided fine-needle biopsy in 385 patients.
    Fornari F, Filice C, Rapaccini GL, Caturelli E, Cavanna L, Civardi G, Di Stasi M, Buscarini E, Buscarini L.
    Dig Dis Sci. 1994 Oct;39(10):2267-75.
  87. Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors.
    Di Stasi M, Sbolli G, Fornari F, Cavanna L, Rossi S, Buscarini E, Civardi G, Vallisa D, Berté R, Buscarini L.
    Oncology. 1994 Sep-Oct;51(5):459-64.
  88. Lytic bone lesions suspected for metastasis: ultrasonically guided fine-needle aspiration biopsy.
    Civardi G, Livraghi T, Colombo P, Fornari F, Cavanna L, Buscarini L.
    J Clin Ultrasound. 1994 Jun;22(5):307-11.
  89. Incidence of gallstones in a population of patients with cirrhosis.
    Fornari F, Imberti D, Squillante MM, Squassante L, Civardi G, Buscarini E, Cavanna L, Caturelli E, Buscarini L.
    J Hepatol. 1994 Jun;20(6):797-801.
  90. Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility.
    Gobbi PG, Bettini R, Montecucco C, Cavanna L, Morandi S, Pieresca C, Merlini G, Bertoloni D, Grignani G, Pozzetti U, et al.
    Blood. 1994 May 15;83(10):2939-45.
  91. Simultaneous relapse of liver cell carcinoma and non-Hodgkin's lymphoma in the liver. Report of a case with diagnosis by ultrasonically guided fine needle aspiration biopsy.
    Cavanna L, Civardi G, Fornari F, Vallisa D, Berte R, Buscarini E, Sbolli G, Paties C, Foroni R, Di Stasi M, et al.
    Acta Cytol. 1994 May-Jun;38(3):451-4.
  92. Vascular signals from pleura-based lung lesions studied with pulsed Doppler ultrasonography.
    Civardi G, Fornari F, Cavanna L, Di Stasi M, Sbolli G, Rossi S, Buscarini E, Buscarini L.
    J Clin Ultrasound. 1993 Nov-Dec;21(9):617-22.
  93. Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trial.
    Brugiatelli M, Federico M, Gobbi PG, Avanzini P, Callea V, Cavanna L, De Pasquale A, Di Prisco AU, Di Rienzo N, Silingardi V, et al.
    Haematologica. 1993 Sep-Oct;78(5):306-12.
  94. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
    Gobbi PG, Pieresca C, Federico M, Di Renzo N, Narni F, Iannitto E, Grignani G, Cavanna L, Avanzini P, Partesotti G, et al.
    J Clin Oncol. 1993 Apr;11(4):712-9.
  95. Acute myelocytic leukemia and chronic myelomonocytic leukemia simultaneously with resectable breast cancer: a report of two cases.
    Cavanna L, Vallisa D, Di Stasi M, Fornari F, Buscarini E, Schena C, Civardi G, Sbolli G, Berte R, Buscarini L.
    Tumori. 1992 Oct 31;78(5):356-8.
  96. Ultrasonically guided percutaneous splenic tissue core biopsy in patients with malignant lymphomas.
    Cavanna L, Civardi G, Fornari F, Di Stasi M, Sbolli G, Buscarini E, Vallisa D, Rossi S, Tansini P, Buscarini L.
    Cancer. 1992 Jun 15;69(12):2932-6.
  97. Ultrasound and ultrasonically guided biopsy in oncohematology.
    Buscarini L, Cavanna L.
    Haematologica. 1991 Jan-Feb;76(1):53-64. Review.
  98. ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
    Federico M, Moretti G, Gobbi PG, Avanzini P, Cavanna L, Carotenuto M, Lombardo M, Leone G, Pitini V, Abbadessa V, et al.
    Leukemia. 1991;5 Suppl 1:95-101.
  99. Diagnostic aspects and follow-up of 174 cases of hepatocellular carcinoma. Second report.
    Buscarini L, Fornari F, Canaletti R, Sbolli G, Civardi G, Cavanna L, Di Stasi M.
    Oncology. 1991;48(1):26-30.
  100. Deep femoral lymphadenectomy with preservation of the fascia lata. Preliminary report on 42 invasive vulvar carcinomas.
    Micheletti L, Borgno G, Barbero M, Preti M, Cavanna L, Nicolaci P, Benedetto C, Ghiringhello B, Bocci A.
    J Reprod Med. 1990 Dec;35(12):1130-3.
  101. Topographic distribution of groin lymph nodes. A study of 50 female cadavers.
    Borgno G, Micheletti L, Barbero M, Cavanna L, Preti M, Valentino MC, Ghiringhello B, Bocci A.
    J Reprod Med. 1990 Dec;35(12):1127-9.
  102. Cirrhosis of the liver. A risk factor for development of cholelithiasis in males.
    Fornari F, Civardi G, Buscarini E, Cavanna L, Imberti D, Rossi S, Sbolli G, Di Stasi M, Buscarini L.
    Dig Dis Sci. 1990 Nov;35(11):1403-8.
  103. Vulvar intraepithelial neoplasia. A clinicopathologic study of 60 cases.
    Barbero M, Micheletti L, Preti M, Cavanna L, Boselli F, Garuti G, Valentino MC, Nicolaci P, Ghiringhello B, Borgno G.
    J Reprod Med. 1990 Nov;35(11):1023-8.
  104. Role of ultrasound guided fine needle aspiration biopsy in the diagnosis of hepatocellular carcinoma.
    Sbolli G, Fornari F, Civardi G, Di Stasi M, Cavanna L, Buscarini E, Buscarini L.
    Gut. 1990 Nov;31(11):1303-5.
  105. Idarubicin plus attenuated high-dose cytosine arabinoside in the treatment of relapsed and refractory acute leukemia.
    Cavanna L, Di Stasi M, Fornari F, Civardi G, Sbolli G, Moretto M, Buscarini L.
    Eur J Haematol. 1990 Sep;45(3):180-1. No abstract available.
  106. Ultrasonically guided fine-needle aspiration biopsy: a highly diagnostic procedure for hepatic tumors.
    Fornari F, Civardi G, Cavanna L, Rossi S, Buscarini E, Di Stasi M, Sbolli G, Buscarini L.
    Am J Gastroenterol. 1990 Aug;85(8):1009-13.
  107. Extramedullary plasmacytoma of the testicle. Sonographic appearance and ultrasonically guided biopsy.
    Cavanna L, Fornari F, Civardi G, Di Stasi M, Sbolli G, Foroni R, Voltolini F, Buscarini L.
    Blut. 1990 Jun;60(6):328-30.
  108. Obstructive jaundice secondary to non-Hodgkin's lymphoma: usefulness of ultrasound-guided fine-needle aspiration biopsy (UG-FNAB).
    Di Stasi M, Cavanna L, Fornari F, Civardi G, Sboli G, Rossi S, Buscarini E, Giacani M, Buscarini L.
    Eur J Haematol. 1990 Apr;44(4):265-6. No abstract available.
  109. Echo Doppler analysis of lymphomatous lymph nodes.
    Cavanna L, Fornari F, Civardi G, Di Stasi M, Buscarini L.
    Blut. 1990 Apr;60(4):257-8. No abstract available.
  110. Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.
    Sbolli G, Zanetti AR, Tanzi E, Cavanna L, Civardi G, Fornari F, Di Stasi M, Buscarini L.
    J Med Virol. 1990 Mar;30(3):230-2.
  111. Ultrasonically guided percutaneous drainage of abdominal fluid collections: a long-term study of its therapeutic efficacy.
    Civardi G, Fornari F, Cavanna L, Sbolli G, Di Stasi M, Buscarini L.
    Gastrointest Radiol. 1990 Summer;15(3):245-50.
  112. Hepatocellular carcinoma associated with other primary malignancies.
    Di Stasi M, Sbolli G, Fornari F, Cavanna L, Civardi G, Rossi S, Buscarini E, Buscarini L.
    Eur J Cancer. 1990;26(5):648-9. No abstract available.
  113. Association of non-Hodgkin's lymphoma and hepatocellular carcinoma.
    Di Stasi M, Cavanna L, Fornari F, Civardi G, Rossi S, Sbolli G, Giacani M, Fermi S, Buscarini L.
    Oncology. 1990;47(1):80-3.
  114. Complications of ultrasonically guided fine-needle abdominal biopsy. Results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group.
    Fornari F, Civardi G, Cavanna L, Di Stasi M, Rossi S, Sbolli G, Buscarini L.
    Scand J Gastroenterol. 1989 Oct;24(8):949-55.
  115. Thoracic and pulmonary involvement by multiple myeloma. Sonographic appearance and ultrasonically-guided biopsy.
    Cavanna L, Civardi G, Fornari F, Di Stasi M, Sbolli G, Giacani M, Buscarini L.
    Eur J Haematol. 1989 Oct;43(4):361-2. No abstract available.
  116. Carcinoma of the esophagus in a hemophiliac infected with the human immunodeficiency virus.
    Cavanna L, Civardi G, Fornari F, Sbolli G, Di Stasi M, Giacani M, Buscarini L.
    Haematologica. 1989 Jul-Aug;74(4):411-2. No abstract available.
  117. Laparoscopic ultrasonography in the study of liver diseases. Preliminary results.
    Fornari F, Civardi G, Cavanna L, Sbolli G, Rossi S, Di Stasi M, Buscarini E, Buscarini L.
    Surg Endosc. 1989;3(1):33-7.
  118. Nodular intracerebral leukemic involvement in the course of acute nonlymphocytic leukemia. Case report and review of the literature.
    Di Stasi M, Cavanna L, Fornari F, Sbolli G, Civardi G, Giacani M, Passerini F, Buscarini L.
    Haematologica. 1989 Jan-Feb;74(1):81-3.
  119. [Absence of liver hematoma after transcutaneous hepatic puncture biopsy in 181 patients: echographic study].
    Sbolli G, Fornari F, Civardi G, Cavanna L, Di Stasi M, Passerini F, Rossi S, Buscarini L.
    Gastroenterol Clin Biol. 1988 Dec;12(12):969. Review. French. No abstract available.
  120. [Condylomata acuminata and vulvar intraepithelial neoplasms (VIN)].
    Barbero M, Micheletti L, Cavanna L, Preti M, Zanotto Valentino MC, Ghiringhello B, Borgno G.
    Minerva Ginecol. 1988 Dec;40(12):743-7. Review. Italian. No abstract available.
  121. [Cervical intraepithelial neoplasia caused by human papillomavirus infection. Cytomorphologic, colposcopic and immunohistochemical correlations].
    Preti M, Micheletti L, Barbero M, Cavanna L, Ghiringhello B, Borgno G.
    Minerva Ginecol. 1988 Oct;40(10):603-6. Review. Italian. No abstract available.
  122. Value of rapid staining and assessment of ultrasound-guided fine needle aspiration biopsies.
    Civardi G, Fornari F, Cavanna L, Di Stasi M, Sbolli G, Buscarini L.
    Acta Cytol. 1988 Jul-Aug;32(4):552-4.
  123. Vulvar dystrophies in young and premenopausal women.
    Barbero M, Micheletti L, Borgno G, Cavanna L, Preti M, Ghiringhello B.
    J Reprod Med. 1988 Jun;33(6):555-8.
  124. Cellular atypia in vulvar dystrophies.
    Micheletti L, Borgno G, Barbero M, Preti M, Cavanna L, Benedetto C, Ghiringhello B.
    J Reprod Med. 1988 Jun;33(6):539-41.
  125. Epithelial alterations adjacent to 111 vulvar carcinomas.
    Borgno G, Micheletti L, Barbero M, Preti M, Cavanna L, Ghiringhello B.
    J Reprod Med. 1988 Jun;33(6):500-2.
  126. Diagnosis of hepatic lesions: ultrasonically guided fine needle biopsy or laparoscopy?
    Fornari F, Rapaccini GL, Cavanna L, Civardi G, Anti M, Fedeli G, Buscarini L.
    Gastrointest Endosc. 1988 May-Jun;34(3):231-4.
  127. Angioimmunoblastic lymphadenopathy with disproteinemia associated with carcinoma. Case report and review of the literature.
    Cavanna L, Di Stasi M, Paties C, Fornari F, Civardi G, Sbolli G, Buscarini L.
    Oncology. 1988;45(4):318-21. Review.
  128. Low-dose cytosine arabinoside in the treatment of acute nonlymphocytic leukemia.
    Cavanna L, Di Stasi M, Fornari F, Civardi G, Sholli G, Montanari G, Buscarini L.
    Acta Haematol. 1988;79(3):179-80. No abstract available.
  129. 240 hepatocellular carcinomas: ultrasound features, tumor size, cytologic and histologic patterns, serum alpha-fetoprotein and HBs Ag.
    Livraghi T, Sangalli G, Giordano F, Ravetto C, Solbiati L, Fornari F, Cavanna L, Matricardi L, Gagliano E.
    Tumori. 1987 Oct 31;73(5):507-12.
  130. Ultrasound and ultrasonically guided biopsy in hepatic lymphoma.
    Cavanna L, Di Stasi M, Fornari F, Civardi G, Sbolli G, Buscarini E, Buscarini L.
    Eur J Cancer Clin Oncol. 1987 Mar;23(3):323-6.
  131. Clinical and diagnostic features of 67 cases of hepatocellular carcinoma.
    Buscarini L, Sbolli G, Cavanna L, Civardi G, Di Stasi M, Buscarini E, Fornari F.
    Oncology. 1987;44(2):93-7.
  132. Diagnostic accuracy of a new tumor serologic marker, CA 19-9: comparison with CEA.
    Civardi G, Cerri L, Cavanna L, Fornari F, Di Stasi M, Binelli F.
    Tumori. 1986 Dec 31;72(6):621-4.
  133. [Diagnosis of vulvar dystrophy].
    Borgno G, Barbero M, Chiara G, Trivelli MR, Cavanna L, Micheletti L.
    Minerva Ginecol. 1986 Dec;38(12):1027-32. Italian. No abstract available.
  134. [Colposcopic investigation of 62,258 subjects. Clinico-statistical considerations].
    Micheletti L, Barbero M, Chiara G, Trivelli MR, Cavanna L, Borgno G.
    Minerva Ginecol. 1986 Nov;38(11):947-51. Italian. No abstract available.
  135. [Echographically guided, percutaneous, fine-needle puncture in the diagnosis of renal masses suspected of malignancy].
    Civardi G, Cavanna L, Fornari F, Di Stasi M, Buscarini E, Buscarini L.
    Recenti Prog Med. 1986 Sep;77(9):420-2. Italian. No abstract available.
  136. [Natural history of active chronic hepatitis. Case contribution].
    Buscarini L, Fornari F, Cavanna L, Rossi S, Buscarini E.
    Minerva Dietol Gastroenterol. 1986 Apr-Jun;32(2):177-81. Italian. No abstract available.
  137. Ultrasonically guided fine needle aspiration biopsy (UG-FNAB): a useful technique for the diagnosis of abdominal malignancies.
    Civardi G, Fornari F, Cavanna L, Di Stasi M, Rossi S, Buscarini E, Buscarini L.
    Eur J Cancer Clin Oncol. 1986 Feb;22(2):225-7. No abstract available.
  138. Anaplastic myeloma as extramedullary relapse of multiple myeloma in remission. Case report and review of the literature.
    Di Stasi M, Cavanna L, Paties C, Fornari F, Civardi G, Binelli F, Buscarini E, Buscarini L.
    Acta Haematol. 1986;76(4):202-7.
  139. T-cell subsets defined by monoclonal antibodies in monoclonal gammopathy of undetermined significance (MGUS).
    Cavanna L, Di Stasi M, Fornari F, Civardi G, Binelli F, Buscarini E, Buscarini L.
    Tumori. 1985 Dec 31;71(6):543-6.
  140. [Natural history of 45 patients with active chronic hepatitis in a general medicine unit].
    Buscarini L, Fornari F, Cavanna L, Rossi S, Buscarini E, Binelli F.
    Clin Ter. 1985 Aug 15;114(3):189-94. Italian. No abstract available.
  141. [Cardioinhibitory carotid sinus syndrome: Holter monitoring does not change the clinical selection of patients for treatment].
    Civardi G, Binelli F, Fornari F, Cavanna L, Rossi S, Buscarini E.
    Clin Ter. 1985 Jul 15;114(1):43-6. Italian. No abstract available.
  142. Ultrasonically guided fine needle aspiration biopsy of abdominal lesions in pathological staging of non-Hodgkin's lymphomas.
    Cavanna L, Fornari F, Buscarini E, Foroni R, Rossi S, Buscarini L.
    Haematologica. 1985 Mar-Apr;70(2):132-5. No abstract available.
  143. Ultrasonically guided fine-needle biopsy: a new useful technique in pathological staging of malignant lymphoma.
    Buscarini L, Cavanna L, Fornari F, Rossi S, Buscarini E.
    Acta Haematol. 1985;73(3):150-2.
  144. Peripheral B and T-cell subsets defined by monoclonal antibodies in patients treated with histamine type-2 receptor antagonists.
    Cavanna L, Fornari F, Groppi F, Tansini P, Rossi S, Prati C, Buscarini L.
    Haematologica. 1984 Jul-Aug;69(4):503-4. No abstract available.
  145. Gastrointestinal involvement in non-Hodgkin's lymphoma. Report of 26 patients.
    Turpini R, Brunati S, Perego M, Trpin L, Cavanna L.
    Haematologica. 1984 Jan-Feb;69(1):30-40. No abstract available.
  146. A study of T lymphocyte subpopulations by monoclonal antibodies in a case of angio-immunoblastic lymphadenopathy with dysproteinemia.
    Cavanna L, Fornari F, Tansini P, Ajolfi C, Rossi S, Prati C, Panelli R, Groppi F, Contini P, Bottinelli S, Silva ML, Buscarini L.
    Haematologica. 1983 May-Jun;68(3):405-10. No abstract available.
  147. [Clinical and therapeutic aspects of Hodgkin's disease involving gastro-intestinal tract. A study of 7 cases (author's transl)].
    Turpini R, Trpin L, Trespi E, Perego M, Charalambakis A, Brunati S, Cavanna L, Mussida M.
    Haematologica. 1979 Dec;64(6):766-76. Italian. No abstract available.
  148. Ultrasound guidance reduces pneumothorax rate and improves safety of thoracentesis in malignant pleural effusion: report on 445 consecutive patients with advanced cancer.
    Cavanna L, Mordenti P, Bertè R, Palladino MA, Biasini C, Anselmi E, Seghini P, Vecchia S, Civardi G, Di Nunzio C. World J Surg Oncol. 2014 May 2;12:139. doi: 10.1186/1477-7819-12-139.
  149. Human herpesvirus 6 encephalitis simulating brain metastases in a patient with advanced small-cell lung cancer.
    Mordenti P, Zaffignani E, Immovilli P, Nobili E, Cavanna L.
    Chemotherapy. 2013;59(5):385-6. doi: 10.1159/000360616. Epub 2014 May 13.
  150. Malignant pleural mesothelioma metastatic to the submandibular salivary gland, simulating glandular hypertrophy, diagnosed by fine-needle aspiration biopsy: a case report and literature review.
    Ambroggi M, Orlandi E, Foroni RP, Cavanna L.
    World J Surg Oncol. 2014 Apr 28;12:129. doi: 10.1186/1477-7819-12-129.
  151. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.
    Bajetta E, Floriani I, Di Bartolomeo M, Labianca R, Falcone A, Di Costanzo F, Comella G, Amadori D, Pinto C, Carlomagno C, Nitti D, Daniele B, Mini E, Poli D, Santoro A, Mosconi S, Casaretti R, Boni C, Pinotti G, Bidoli P, Landi L, Rosati G, Ravaioli A, Cantore M, Di Fabio F, Aitini E, Marchet A; ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group.
    Ann Oncol. 2014 Jul;25(7):1373-8. doi: 10.1093/annonc/mdu146. Epub 2014 Apr 12.
  152. -Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey
    Natoli C, Brocco D, Sperduti I, Nuzzo A, Tinari N, De Tursi M, Grassadonia A, Mazzilli L, Iacobelli S, Gamucci T, Vici P; "FOLLOW-UP" Study Group.
    PLoS One. 2014 Apr 8;9(4):e94063. doi: 10.1371/journal.pone.0094063. eCollection 2014.
  153. Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.
    Guarneri V, Generali DG, Frassoldati A, Artioli F, Boni C, Cavanna L, Tagliafico E, Maiorana A, Bottini A, Cagossi K, Bisagni G, Piacentini F, Ficarra G, Bettelli S, Roncaglia E, Nuzzo S, Swaby R, Ellis C, Holford C, Conte P.
    J Clin Oncol. 2014 Apr 1;32(10):1050-7. doi: 10.1200/JCO.2013.51.4737. Epub 2014 Mar 3.
  154. Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.
    Gridelli C, Rossi A, Di Maio M, Leo S, Filipazzi V, Favaretto AG, Burgio MA, Cinieri S, Bianco R, Ciardiello F, Cavanna L, Bordonaro R, Costanzo R, Sandomenico C, Gallo C, Perrone F, Morabito A.
    Clin Lung Cancer. 2014 Mar;15(2):166-70. doi: 10.1016/j.cllc.2013.11.011. Epub 2013 Nov 20.
  155. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
    Visani M, de Biase D, Marucci G, Cerasoli S, Nigrisoli E, Bacchi Reggiani ML, Albani F, Baruzzi A, Pession A; PERNO study group.
    Mol Oncol. 2014 Mar;8(2):417-30. doi: 10.1016/j.molonc.2013.12.010. Epub 2013 Dec 24.
  156. Solitary fibrous tumors of the pleura: a case report and review of the literature.
    Mordenti P, Di Cicilia R, Delfanti R, Capelli P, Paties C, Cavanna L.
    Tumori. 2013 Jul-Aug;99(4):e177-83. doi: 10.1700/1361.15120. Review.
  157. Edoxaban versus warfarin in patients with atrial fibrillation.
    Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.
    N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.
  158. Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology).
    Michelucci R, Pasini E, Meletti S, Fallica E, Rizzi R, Florindo I, Chiari A, Monetti C, Cremonini AM, Forlivesi S, Albani F, Baruzzi A; PERNO Study Group.
    Epilepsia. 2013 Oct;54 Suppl 7:86-91. doi: 10.1111/epi.12314. Review.
  159. Central venous catheter care for the patients with cancer: ultrasound-guided insertion should be strongly recommended for internal jugular vein catheterization.
    Cavanna L, Civardi G, Mordenti P, Vallisa D, Bertè R, Di Nunzio C.
    Ann Oncol. 2013 Nov;24(11):2928-9. doi: 10.1093/annonc/mdt387. Epub 2013 Oct 7. No abstract available.
  160. Two year follow-up results of the CARDIAC (CARDIomyoplasty by Autologous intraCoronary bone marrow in acute myocardial infarction) randomised controlled trial.
    Piepoli MF, Vallisa D, Arbasi C, Cavanna L, Cerri L, Mori M, Passerini F, Tommasi L, Rossi A, Capucci A; Cardiac Study Group.
    Int J Cardiol. 2013 Oct 12;168(5):e132. doi: 10.1016/j.ijcard.2013.08.032. Epub 2013 Aug 15. No abstract available.
  161. Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
    Garassino MC, Martelli O, Broggini M, Farina G, Veronese S, Rulli E, Bianchi F, Bettini A, Longo F, Moscetti L, Tomirotti M, Marabese M, Ganzinelli M, Lauricella C, Labianca R, Floriani I, Giaccone G, Torri V, Scanni A, Marsoni S; TAILOR trialists.
    Lancet Oncol. 2013 Sep;14(10):981-8. doi: 10.1016/S1470-2045(13)70310-3. Epub 2013 Jul 22.
  162. Reduction of fear and acute toxicity from chemotherapy with a telephone call after the first cycle.
    Mordenti P, Capuano DL, Zanlari L, Achilli R, Galli ML, Marazzi E, Gandolfi S, Granelli B, Terzoni D, Civardi G, Cavanna L.
    J Pain Symptom Manage. 2013 Aug;46(2):e6-9. doi: 10.1016/j.jpainsymman.2013.02.026. Epub 2013 Jul 5. No abstract available.
  163. Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study
    Morabito A, Gebbia V, Di Maio M, Cinieri S, Viganò MG, Bianco R, Barbera S, Cavanna L, De Marinis F, Montesarchio V, Costanzo R, Sandomenico C, Montanino A, Mancuso G, Russo P, Nacci A, Giordano P, Daniele G, Piccirillo MC, Rocco G, Gridelli C, Gallo C, Perrone F.
    Lung Cancer. 2013 Jul;81(1):77-83. doi: 10.1016/j.lungcan.2013.04.008. Epub 2013 May 1.
  164. Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
    Alessandrino EP, Porta MG, Malcovati L, Jackson CH, Pascutto C, Bacigalupo A, Teresa van Lint M, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Rambaldi A, Bosi A, Cazzola M; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Am J Hematol. 2013 Jul;88(7):581-8. doi: 10.1002/ajh.23458. Epub 2013 May 30.
  165. Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference.
    Visani M, de Biase D, Marucci G, Taccioli C, Baruzzi A, Pession A; PERNO Study Group.
    PLoS One. 2013;8(1):e55314. doi: 10.1371/journal.pone.0055314. Epub 2013 Jan 29.
  166. Primary dural lymphoma mimicking a chronic epidural hematoma. Differential diagnosis of two rare conditions.
    Iaccarino C, Schiavi P, Crafa P, Bronzoni C, Ramponi V, Mantenuto G, Cavanna L, Servadei F.
    Clin Neurol Neurosurg. 2013 Aug;115(8):1510-3. doi: 10.1016/j.clineuro.2012.12.013. Epub 2013 Jan 3. No abstract available.
  167. Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.
    Di Maio M, Leighl NB, Gallo C, Feld R, Ciardiello F, Butts C, Maione P, Gebbia V, Morgillo F, Wierzbicki R, Favaretto A, Alam Y, Cinieri S, Siena S, Bianco R, Riccardi F, Spatafora M, Ravaioli A, Felletti R, Fregoni V, Genestreti G, Rossi A, Mancuso G, Fasano M, Morabito A, Tsao MS, Signoriello S, Perrone F, Gridelli C; TORCH Investigators.
    J Thorac Oncol. 2012 Dec;7(12):1830-44. doi: 10.1097/JTO.0b013e318275b327.
  168. Inversion time prolongation at late enhancement cardiac MRI in a myeloma patient.
    Belloni E, Marchesi G, Aschieri D, Bernuzzi P, Trabacchi E, Vallisa D, Villani GQ, Cavanna L, Michieletti E.
    Diagn Interv Radiol. 2012 Nov-Dec;18(6):552-4. doi: 10.4261/1305-3825.DIR.5923-12.2.
  169. Metastatic breast cancer to the gastrointestinal tract: report of five cases and review of the literature.
    Ambroggi M, Stroppa EM, Mordenti P, Biasini C, Zangrandi A, Michieletti E, Belloni E, Cavanna L.
    Int J Breast Cancer. 2012;2012:439023. doi: 10.1155/2012/439023. Epub 2012 Oct 4.
  170. Ultrasound guidance reduces pneumothorax rate and improves safety of thoracentesis in malignant pleural effusion: report on 445 consecutive patients with advanced cancer.
    Cavanna L, Mordenti P, Bertè R, Palladino MA, Biasini C, Anselmi E, Seghini P, Vecchia S, Civardi G, Di Nunzio C.
    World J Surg Oncol. 2014 May 2;12:139. doi: 10.1186/1477-7819-12-139.
  171. Human herpesvirus 6 encephalitis simulating brain metastases in a patient with advanced small-cell lung cancer.
    Mordenti P, Zaffignani E, Immovilli P, Nobili E, Cavanna L.
    Chemotherapy. 2013;59(5):385-6. doi: 10.1159/000360616. Epub 2014 May 13.
  172. Malignant pleural mesothelioma metastatic to the submandibular salivary gland, simulating glandular hypertrophy, diagnosed by fine-needle aspiration biopsy: a case report and literature review.
    Ambroggi M, Orlandi E, Foroni RP, Cavanna L.
    World J Surg Oncol. 2014 Apr 28;12:129. doi: 10.1186/1477-7819-12-129.
  173. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.
    Bajetta E, Floriani I, Di Bartolomeo M, Labianca R, Falcone A, Di Costanzo F, Comella G, Amadori D, Pinto C, Carlomagno C, Nitti D, Daniele B, Mini E, Poli D, Santoro A, Mosconi S, Casaretti R, Boni C, Pinotti G, Bidoli P, Landi L, Rosati G, Ravaioli A, Cantore M, Di Fabio F, Aitini E, Marchet A; ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group.
    Ann Oncol. 2014 Jul;25(7):1373-8. doi: 10.1093/annonc/mdu146. Epub 2014 Apr 12.
  174. Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.
    Natoli C, Brocco D, Sperduti I, Nuzzo A, Tinari N, De Tursi M, Grassadonia A, Mazzilli L, Iacobelli S, Gamucci T, Vici P; "FOLLOW-UP" Study Group.
    PLoS One. 2014 Apr 8;9(4):e94063. doi: 10.1371/journal.pone.0094063. eCollection 2014.
  175. Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.
    Guarneri V, Generali DG, Frassoldati A, Artioli F, Boni C, Cavanna L, Tagliafico E, Maiorana A, Bottini A, Cagossi K, Bisagni G, Piacentini F, Ficarra G, Bettelli S, Roncaglia E, Nuzzo S, Swaby R, Ellis C, Holford C, Conte P.
    J Clin Oncol. 2014 Apr 1;32(10):1050-7. doi: 10.1200/JCO.2013.51.4737. Epub 2014 Mar 3.
  176. Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.
    Gridelli C, Rossi A, Di Maio M, Leo S, Filipazzi V, Favaretto AG, Burgio MA, Cinieri S, Bianco R, Ciardiello F, Cavanna L, Bordonaro R, Costanzo R, Sandomenico C, Gallo C, Perrone F, Morabito A.
    Clin Lung Cancer. 2014 Mar;15(2):166-70. doi: 10.1016/j.cllc.2013.11.011. Epub 2013 Nov 20.
  177. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
    Visani M, de Biase D, Marucci G, Cerasoli S, Nigrisoli E, Bacchi Reggiani ML, Albani F, Baruzzi A, Pession A; PERNO study group.
    Mol Oncol. 2014 Mar;8(2):417-30. doi: 10.1016/j.molonc.2013.12.010. Epub 2013 Dec 24.
  178. Solitary fibrous tumors of the pleura: a case report and review of the literature.
    Mordenti P, Di Cicilia R, Delfanti R, Capelli P, Paties C, Cavanna L.
    Tumori. 2013 Jul-Aug;99(4):e177-83. doi: 10.1700/1361.15120. Review.
  179. Edoxaban versus warfarin in patients with atrial fibrillation.
    Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.
    N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.
  180. Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology).
    Michelucci R, Pasini E, Meletti S, Fallica E, Rizzi R, Florindo I, Chiari A, Monetti C, Cremonini AM, Forlivesi S, Albani F, Baruzzi A; PERNO Study Group.
    Epilepsia. 2013 Oct;54 Suppl 7:86-91. doi: 10.1111/epi.12314. Review.
  181. Central venous catheter care for the patients with cancer: ultrasound-guided insertion should be strongly recommended for internal jugular vein catheterization.
    Cavanna L, Civardi G, Mordenti P, Vallisa D, Bertè R, Di Nunzio C.
    Ann Oncol. 2013 Nov;24(11):2928-9. doi: 10.1093/annonc/mdt387. Epub 2013 Oct 7. No abstract available.
  182. Two year follow-up results of the CARDIAC (CARDIomyoplasty by Autologous intraCoronary bone marrow in acute myocardial infarction) randomised controlled trial.
    Piepoli MF, Vallisa D, Arbasi C, Cavanna L, Cerri L, Mori M, Passerini F, Tommasi L, Rossi A, Capucci A; Cardiac Study Group.
    Int J Cardiol. 2013 Oct 12;168(5):e132. doi: 10.1016/j.ijcard.2013.08.032. Epub 2013 Aug 15. No abstract available.
  183. Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
    Garassino MC, Martelli O, Broggini M, Farina G, Veronese S, Rulli E, Bianchi F, Bettini A, Longo F, Moscetti L, Tomirotti M, Marabese M, Ganzinelli M, Lauricella C, Labianca R, Floriani I, Giaccone G, Torri V, Scanni A, Marsoni S; TAILOR trialists.
    Lancet Oncol. 2013 Sep;14(10):981-8. doi: 10.1016/S1470-2045(13)70310-3. Epub 2013 Jul 22.
  184. Reduction of fear and acute toxicity from chemotherapy with a telephone call after the first cycle.
    Mordenti P, Capuano DL, Zanlari L, Achilli R, Galli ML, Marazzi E, Gandolfi S, Granelli B, Terzoni D, Civardi G, Cavanna L.
    J Pain Symptom Manage. 2013 Aug;46(2):e6-9. doi: 10.1016/j.jpainsymman.2013.02.026. Epub 2013 Jul 5. No abstract available.
  185. Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
    Morabito A, Gebbia V, Di Maio M, Cinieri S, Viganò MG, Bianco R, Barbera S, Cavanna L, De Marinis F, Montesarchio V, Costanzo R, Sandomenico C, Montanino A, Mancuso G, Russo P, Nacci A, Giordano P, Daniele G, Piccirillo MC, Rocco G, Gridelli C, Gallo C, Perrone F.
    Lung Cancer. 2013 Jul;81(1):77-83. doi: 10.1016/j.lungcan.2013.04.008. Epub 2013 May 1.
  186. Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
    Alessandrino EP, Porta MG, Malcovati L, Jackson CH, Pascutto C, Bacigalupo A, Teresa van Lint M, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Rambaldi A, Bosi A, Cazzola M; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Am J Hematol. 2013 Jul;88(7):581-8. doi: 10.1002/ajh.23458. Epub 2013 May 30.
  187. Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference.
    Visani M, de Biase D, Marucci G, Taccioli C, Baruzzi A, Pession A; PERNO Study Group.
    PLoS One. 2013;8(1):e55314. doi: 10.1371/journal.pone.0055314. Epub 2013 Jan 29.
  188. Primary dural lymphoma mimicking a chronic epidural hematoma. Differential diagnosis of two rare conditions.
    Iaccarino C, Schiavi P, Crafa P, Bronzoni C, Ramponi V, Mantenuto G, Cavanna L, Servadei F.
    Clin Neurol Neurosurg. 2013 Aug;115(8):1510-3. doi: 10.1016/j.clineuro.2012.12.013. Epub 2013 Jan 3. No abstract available.
  189. Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.
    Di Maio M, Leighl NB, Gallo C, Feld R, Ciardiello F, Butts C, Maione P, Gebbia V, Morgillo F, Wierzbicki R, Favaretto A, Alam Y, Cinieri S, Siena S, Bianco R, Riccardi F, Spatafora M, Ravaioli A, Felletti R, Fregoni V, Genestreti G, Rossi A, Mancuso G, Fasano M, Morabito A, Tsao MS, Signoriello S, Perrone F, Gridelli C; TORCH Investigators.
    J Thorac Oncol. 2012 Dec;7(12):1830-44. doi: 10.1097/JTO.0b013e318275b327.
  190. Inversion time prolongation at late enhancement cardiac MRI in a myeloma patient.
    Belloni E, Marchesi G, Aschieri D, Bernuzzi P, Trabacchi E, Vallisa D, Villani GQ, Cavanna L, Michieletti E.
    Diagn Interv Radiol. 2012 Nov-Dec;18(6):552-4. doi: 10.4261/1305-3825.DIR.5923-12.2.
  191. Metastatic breast cancer to the gastrointestinal tract: report of five cases and review of the literature.
    Ambroggi M, Stroppa EM, Mordenti P, Biasini C, Zangrandi A, Michieletti E, Belloni E, Cavanna L.
    Int J Breast Cancer. 2012;2012:439023. doi: 10.1155/2012/439023. Epub 2012 Oct 4.